1. Voronina TA. Mexidol: main neuropsychotropic effects and mechanisms of action. Farmateka. 2009;6:28-31. (In Russ.)
2. Voronina TA. Mexidol: the spectrum of pharmacological effects. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2012;112(12):86-90. Accessed October 16, 2018. (In Russ.) https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2012/12/031997-729820121215
3. Schulkin AV. Mexidol: modern aspects of the pharmacokinetics and pharmacodynamics. Farmateka. 2016;4:65-71. (In Russ.)
4. Okunevich IV, Sapronov NS. Antioksidanty: effektivnost' prirodnykh i sinteticheskikh soedinenii v kompleksnoi terapii serdechno-sosudistykh zabolevanii. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii. 2004;3(3):2-17. Accessed October 16, 2018. (In Russ.) https://elibrary.ru/item.asp?id=9288234
5. Vladimirov YuA. Svobodnye radikaly i antioksidanty. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 1998;7:43-51. (In Russ.)